Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
01/2008
01/08/2008CA2258712C Asymetric synthesis of chiral beta-amino acids
01/03/2008WO2008002087A1 Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use
01/03/2008US20080004455 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
01/03/2008US20080004451 Pseudo proline dipeptides
01/03/2008US20080004415 Non-linear optically active molecules, their synthesis, and use
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004321 Potentiators of Glutamate Receptors
01/03/2008DE102006029830A1 Growing of deuterated alanine doped triglycine sulfate monocrystals from a solution for night vision device, comprises arranging a crystal holder in a chamber of a device and pumping the solution in a circulation with the chamber
01/02/2008EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
01/02/2008CN101096345A Method for preparing chirality 2-hydroxyl group-3-amino-benzene ethylformic acid or its ester
01/01/2008US7314955 Crystalline form "C"; amidating D-phenylalanine methyl ester hydrocholoride with trans-4-isopropylcyclohexane carboxylic acid in a halogenated hydrocarbon; hydrolyzing to form free acid
01/01/2008US7314951 Biodegradation%
01/01/2008US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed
01/01/2008US7314890 7-[[5-Hydroxy-5-(1-propylcyclobutyl)pent-2enyl] methanesulfonylamino] heptanoic acid ethyl ester; lowering intraocular pressure, glaucoma
01/01/2008US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
12/2007
12/27/2007WO2007045593A3 Naphthyl derivatives as inhibitors of beta-amyloid aggregation
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/27/2007US20070298129 Compounds and compositions for treating neuronal death or neurological dysfunction
12/26/2007EP1870403A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing -amino acid and derivative thereof with the same
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1868985A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/26/2007CN200995995Y Co-production line of lysine with different purities
12/26/2007CN101092373A Method for synthesizing optically active derivative of 5 ¿C aryl ¿C (S) ¿C N ¿C boc ¿C alpha amino pentanoic acid
12/26/2007CN101092372A Method for practical synthesizing optically active alpha amino pimelic acid ester or monoester
12/26/2007CN101092371A Method for synthesizing optically active derivative of omega - aryl ¿C (2S) ¿C N ¿C boc ¿Calpha amino acid
12/26/2007CN101092370A Method for practical synthesizing optically active 2 ¿C amido ¿C 8 - butenic acid
12/26/2007CN101092369A Method for preparing iminodiacetic acid by using raw material of hydroxy acetonitrile
12/26/2007CN101092368A Method for synthesizing 2 ¿C amido ¿C 9 - capric olefine acid
12/26/2007CN100357274C Diaryl-enynes
12/26/2007CN100357258C Production of keto acids
12/25/2007US7312361 Inhibitors of transthyretin amyloid fibril formation
12/25/2007US7312353 Cathespin cysteine protease inhibitors
12/25/2007US7312343 N-benzyl-protected dialkyl acetal derivatives undergo desired aldol reaction with high diastereoselectivity using a Mukaiyama aldol reaction; intermediates in the synthesis of other products, including, e.g. Dolastatin 10
12/25/2007US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast
12/20/2007US20070293700 Process for the Preparation of Gabapentin
12/20/2007US20070293694 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
12/20/2007US20070293573 Glu2 receptor modulators
12/20/2007US20070293567 Substituted biphenyl carboxylic acids and derivatives thereof
12/20/2007US20070293547 Compounds and Compositions as Lxr Modulators
12/19/2007EP1866275A1 Crystalline forms of pregabalin
12/19/2007EP1313560B1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
12/19/2007CN100355723C Dimeglumine gadopentetate and its producing method
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/13/2007WO2007143152A2 Preparation of (s)-pregabalin-nitrile
12/13/2007US20070287861 A Process Suitable for Industrial Scale Production of Gabapentin
12/13/2007US20070287748 Intermediate in the synthesis of (S)-Pregabalin; precipitation
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1863780A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
12/12/2007EP1863755A1 Substituted aryl and heteroaryl derivatives
12/12/2007EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
12/12/2007CN101087752A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics
12/12/2007CN101085875A Pigment dispersant and its preparation method and application
12/12/2007CN101085745A Modified synthesis method for L-theanine
12/12/2007CN100354256C Preparation of iminodiacetic acid compounds from monoethanolamine substrates
12/12/2007CN100354251C Fused bicyclic or tricyclic amino acids
12/11/2007US7307187 Oxidation of lauroyl monoalkanolamide with NaOBr, bromosuccinimide, bromoisocyanuric acid, oxone, or H2O2 and a hindered nitroxide; THF solvent creates two liquid phases separating the amidoalcohol from the oxidizing agent, amidoalcohol is partitioned into the liquid organic phase
12/06/2007WO2007139724A1 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom
12/06/2007WO2007139238A1 Process for l-carnitine and acetyl l-carnitine hydrochloride
12/06/2007WO2007138324A2 Materials and complexes for the delivery of biologically-active material to cells
12/06/2007WO2007137799A1 New synthesis of substituted hydroxymethyl phenols
12/06/2007WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
12/06/2007US20070282127 strontium salt of an organic dicarboxylic acid, e.g. strontium malonate of high purity; reacting strontium hydroxide or strontium chloride with diacid in aqueous solution at given tempeature, pressure and molar ratio; end use as pharmaceutical, fertilizer, vitamins, in industrial products
12/06/2007US20070281969 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/06/2007CA2650510A1 Materials and complexes for the delivery of biologically-active material to cells
12/06/2007CA2649115A1 Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
12/06/2007CA2647398A1 New synthesis of substituted hydroxymethyl phenols
12/05/2007EP1862446A2 Method for manufacturing enantiomer-enriched hydroxylamine derivatives
12/05/2007EP1678198A4 Side chain deuterated amino acids and methods of use
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
12/05/2007EP1268397B1 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007EP1052968B1 Alpha-amides of(l)-amino acids as fragrance precursors
12/05/2007CN101081820A (Z)-4,4,4-trifluoro-3-hydroxyl-2-(dibenzyl amido)-2-butenoic acid ethyl and preparation method thereof
12/05/2007CN100352803C Ethyl glycinate hydrochloride production method
12/05/2007CN100352802C Contrast agent preparation
12/05/2007CN100352801C Synthesis method of L-n-valaine
12/04/2007US7304181 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
11/2007
11/29/2007US20070276036 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof
11/29/2007US20070275858 Substituted spirocyclic ketoenols
11/29/2007CA2652259A1 Substituted esters as cannabinoid-1 receptor modulators
11/28/2007EP1860098A1 Novel anthranilic acid derivative or salt thereof
11/28/2007EP1860094A1 Photocrosslinkable materials
11/28/2007EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077862A D-glucose-L-amino acid, preparation method and application thereof
11/27/2007US7301031 Methods for producing hydroxy amino acids, esters, and derivatives thereof
11/27/2007US7300775 Genetic engineered nucleic acid promoter
11/22/2007WO2007132689A1 Process for production of radioactive fluorine-labeled organic compound
11/22/2007WO2007132119A1 In situ or one-pot hydrogenation and reductive amination method
11/22/2007WO2006108663A8 Method for recovering a basic amino acid from a fermentation liquor
11/22/2007US20070270306 dehydrogenation of alcohols in the presence of doped hydrogenation catalysts, to form carboxylic acids and salts
11/22/2007CA2651786A1 Process for production of radioactive fluorine-labeled organic compound
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical
11/20/2007US7297820 Thio substituted stilbene amines; inhibiting the aggregation of amyloid proteins
11/20/2007CA2139374C Polyaminated ligands and metal complexes thereof
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 215